Calreticulin Exon 9 Mutation test

Test description

Calreticulin (CALR) exon 9 mutations are seen in a number of myeloproliferative neoplasms. Consider CALR mutations in conjunction with or following other molecular tests for these disorders.

Test information

Test name

CALR (Calreticulin)

Clinical indication

In the diagnostic workup of myeloproliferative neoplasms. This test is now only offered as part of the Myeloproliferative Neoplasm (MPN) panel of 31 genes.

Gene(s)

CALR

Method

NGS (Next Generation Sequencing)

Turn around time

3 – 4 weeks

Medicare eligibility

73398 or 73399 – criteria apply

Price

If not MBS eligible please contact 1800 822 999 for details

Test request form

Standard pathology request form

Sample type

Blood EDTA 6mL or Bone Marrow EDTA 4mL

Collection type

Blood or bone marrow

Special instructions

None